Clinical trials
Pediatric ALL clinical trials
Below are recruiting pediatric all clinical trials, each written for real people, not researchers. We’re tracking 1,358 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06055959RecruitingPhase 2/Phase 3
Zilucoplan for children with generalized myasthenia gravis
This study tests a new daily shot (zilucoplan) for children and teens with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. It aims to see if the drug is safe and helps improve strength and daily functioning.
Chicago, IllinoisAges 12–17 - NCT06041685Recruiting
Warming for artery catheter in children under 2
This trial tests if warming the skin before placing an artery line helps children having heart surgery. It may make the procedure easier and more comfortable.
Yangsan, Gyeongsangnam-doAges Up to 2 years - NCT06055712Enrolling by invitationPhase 4
Antibiotics for children with open fractures
This trial tests whether giving antibiotics can prevent infections in children with mild open fractures (grade 1 or 2) that don't need surgery. It aims to find a safer, simpler treatment plan.
St Louis, MissouriAges birth–17 years - NCT06055296Recruiting
Supporting Hispanic families in pediatric cancer clinical trials
This study helps Hispanic families with a child newly diagnosed with cancer understand their options when a clinical trial is offered. It looks at how to better support parents during the informed consent process.
Birmingham, AlabamaAges 18 years+ - NCT06040255Enrolling by invitationPhase 4
Steroid treatment for focal brain artery inflammation in children
This trial tests whether short-term steroids improve recovery for children who recently had a stroke or mini-stroke caused by inflammation of a brain artery. If you qualify, you would receive steroids and follow-up imaging to see if it helps prevent further damage.
San Francisco, CaliforniaAges 1–18 - NCT06047977RecruitingPhase 1
Immune cell therapy for high-risk solid tumors in children and young adults
This trial uses a patient's own tumor-fighting immune cells (TILs) to treat high-risk solid tumors outside the brain in children and young adults. It has two parts: first, a tumor sample is collected during surgery, and then the immune cells are grown in a lab and given back to the patient to attack the cancer.
St. Petersburg, FloridaAges 1–21 - NCT06034392Enrolling by invitation
CHAMP app study for kids with complex heart conditions
This study tests whether using a mobile app to monitor children with complex health conditions at home can help their care team. Families will use the app to share health information instead of only in clinic visits.
Washington D.C., District of ColumbiaAges Up to 18 years - NCT06036199Recruiting
Focused ultrasound for movement problems in cerebral palsy
This trial tests if focused ultrasound can help reduce uncontrolled movements in children and young adults with cerebral palsy caused by a lack of oxygen at birth. It may offer an option for those whose current medications aren't working well enough.
Washington D.C., District of ColumbiaAges 8–22 - NCT06025734Recruiting
Nerve stimulation for bladder control in spina bifida
This study tests whether stimulating a nerve in the leg (the tibial nerve) with a small device can help children with spina bifida who leak urine even when using a catheter. The treatment is non-invasive, like a tiny electrical patch near the ankle, and aims to improve bladder control.
Dallas, TexasAges 8–18 - NCT05995353RecruitingPhase 3
Risankizumab for children with moderate to severe Crohn's
This study tests a new medicine called risankizumab for children with moderate to severe Crohn's disease. It is given as an IV infusion or a shot under the skin to see if it can reduce inflammation and improve symptoms.
Phoenix, ArizonaAges 2–17 - NCT05981664Recruiting
Can adaptive gaming help kids with arm differences?
This study explores whether playing video games with adapted controls can help children aged 7 to 17 who have a missing or different arm or hand. It tests how fun and useful these games are for improving movement and daily life.
Winnipeg, ManitobaAges 7–17 - NCT05981300Recruiting
Pediatric Gastroparesis Research Registry
This study collects information from children and young adults with gastroparesis (a condition where the stomach empties slowly). It helps researchers understand how this condition affects people over time.
Boston, MassachusettsAges 8–25 - NCT05999032Recruiting
Puerto Rico Asthma Integrated Response Program for children
This study tests a program to help children aged 2 to 12 with asthma that is not well controlled. The program provides support and resources to improve asthma management at home.
Providence, Rhode IslandAges 2–12 - NCT04299191RecruitingPhase 1/Phase 2
LAM561 for children with advanced brain or solid tumors
This Phase 1/2 study tests a medicine called LAM561 in children whose cancer is advanced and not responding to standard treatment. The goal is to see if the drug is safe and can shrink or control tumors in this setting.
Little Rock, ArkansasAges Up to 18 years - NCT05947071RecruitingPhase 2
Higher-dose flu vaccine versus standard dose in child transplant patients
This trial compares a higher-dose flu vaccine to the standard dose in children who recently received a kidney, heart, and/or liver transplant. It aims to see which dose better protects children against influenza while checking for safety.
Stanford, CaliforniaAges 3–17 - NCT05955261RecruitingPhase 2
Study of adding venetoclax to standard chemotherapy for pediatric AML
This trial tests a new combination of a targeted pill (venetoclax) with standard chemotherapy for children and young adults with acute myeloid leukemia (AML). The hope is that adding venetoclax will improve how well the chemo works and reduce the chance of the leukemia coming back.
Madera, CaliforniaAges 4 weeks–21 years - NCT05948943RecruitingPhase 2/Phase 3
Alpelisib for lymphatic malformations with a PIK3CA change
This trial tests alpelisib (a targeted medicine) for people who have lymphatic malformations (LyM) that cause symptoms and have a PIK3CA mutation. It may help shrink or control these lesions when other procedures are delayed until after the first 24 weeks.
Oakland, CaliforniaAges birth–100 years - NCT05953584RecruitingPhase 2
Etavopivat for preventing stroke risk in sickle cell children
This trial studies etavopivat to see if it can improve blood-flow measurements in the brain that predict future stroke risk in children with sickle cell disease. If you qualify, you would take the study medicine and be monitored with brain blood-flow testing.
Raipur, ChhattisgarhAges 12–16 - NCT02914067Recruiting
Testing brain scan and computer measures in young brain tumor patients
This study looks at “brain biomarkers,” meaning brain signals measured on MRI and thinking/learning tests on a computer. It may help researchers understand how brain tumors affect the brain and track changes over time.
St Louis, MissouriAges 4–18 - NCT05923073RecruitingPhase 3
Guselkumab for children with active Crohn’s disease
This Phase 3 trial tests guselkumab to treat children with moderately to severely active Crohn’s disease and ongoing inflammation in the bowel. If you qualify, the study will check whether the medicine can improve symptoms and healing, especially in children who did not respond to other treatments.
Los Angeles, CaliforniaAges 2–17 - NCT05918640RecruitingPhase 1/Phase 2
Lurbinectedin for cancers with specific EWS-related gene fusions
This early-phase study tests lurbinectedin, a chemotherapy medicine, in children and young adults whose solid tumors have a specific “FET fusion” gene change. It may help shrink tumors that have come back or did not respond to prior treatment, depending on the exact fusion type.
Los Angeles, CaliforniaAges 10 years+ - NCT05931913Recruiting
TMS plus exposure therapy for teenage OCD
This study tests whether combining transcranial magnetic stimulation (TMS) with exposure therapy can help reduce OCD symptoms in young people aged 12-21. TMS is a non-invasive brain stimulation technique. The study aims to see if this combination is more effective than exposure therapy alone.
Minneapolis, MinnesotaAges 12–21 - NCT05939570Recruiting
Study about surgery day cancellations and neighborhood support
This study asks parents or guardians of children who had a surgery day canceled. It looks at how neighborhood circumstances may affect care, and it only includes families who speak specific languages.
Columbus, OhioAges Up to 18 years - NCT05917626Recruiting
Digital program for teens with long-lasting pain
This trial studies whether a digital (phone or computer) program can help teens (ages 12–17) manage chronic pain over time. It’s designed with input from patients and may also show how well the program can be used in real life with families.
Almería, AlmeríaAges 12–17
Hear when a new Pediatric ALL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pediatric all?
- Yes. Clin2 currently lists 1,358 recruiting pediatric all studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pediatric all trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pediatric all trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Beyond the search
We also like to point to nonprofits doing real good in this area. We aren’t affiliated with them — we just admire the work.
- Children’s Oncology Support FundChildren with cancer and the families caring for them.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.